Literature DB >> 28382508

Clinicopathological characteristics of typical and atypical anti-glomerular basement membrane nephritis.

Vincenzo L'Imperio1, Elena Ajello2, Federico Pieruzzi2, Manuela Nebuloni3, Antonella Tosoni3, Franco Ferrario1, Fabio Pagni4.   

Abstract

Anti-glomerular basement membrane (GBM) antibody disease is a rare pathological condition that mainly involves renal and/or pulmonary parenchyma. It is characterized by the presence of circulating anti-GBM antibodies accompanied by a linear deposition of immunoglobulins (Ig) detected through immunofluorescence (IF) technique and typical signs and symptoms of organ dysfunction, such as rapidly progressive glomerulonephritis (RPGN) and pulmonary hemorrhage (PH). However, recently atypical forms of anti-GBM disease have been described and the presence of overlapping diseases contributed to make its diagnosis challenging. In this review will be discussed the entire spectrum of renal anti-GBM related conditions, focusing the attention on the differences in terms of pathogenesis, diagnosis and therapy of these disparate entities.

Entities:  

Keywords:  Anti-GBM disease; Crescentic glomerulonephritis; Nephropathology; Rapidly progressive glomerulonephritis

Mesh:

Substances:

Year:  2017        PMID: 28382508     DOI: 10.1007/s40620-017-0394-x

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  3 in total

1.  Granulomatosis With Polyangiitis Presenting as Complete Hearing Loss.

Authors:  Brandon H Busch; David Wilhelm; Paul Johnson; Mark Pfeifer
Journal:  Cureus       Date:  2022-05-03

2.  Anti-glomerular basement membrane disease with IgA nephropathy: A case report.

Authors:  Chuan Guo; Ming Ye; Shen Li; Ting-Ting Zhu; Xiang-Rong Rao
Journal:  World J Clin Cases       Date:  2022-04-26       Impact factor: 1.534

Review 3.  Goodpasture's autoimmune disease - A collagen IV disorder.

Authors:  Vadim Pedchenko; A Richard Kitching; Billy G Hudson
Journal:  Matrix Biol       Date:  2018-05-12       Impact factor: 11.583

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.